Institutional Career Development Core (KL2)
机构职业发展核心(KL2)
基本信息
- 批准号:9903516
- 负责人:
- 金额:$ 110.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAcademyAddressAppointmentAreaAttitudeBehaviorBiomedical EngineeringBiomedical ResearchClinical MedicineClinical ResearchCollaborationsCommunitiesCompetenceCritical ThinkingCustomDevelopmentDevelopment PlansEducationElectronic MailElementsEnrollmentEpidemiologyEvaluationFacultyFellowshipFundingFutureGood Clinical PracticeGovernmentGrantHealth TechnologyHome environmentHomogeneously Staining RegionIndividualIndustryInstructionJournalsKnowledgeLeadershipLife Cycle StagesLongevityMalignant NeoplasmsManuscriptsMedicineMentorsNappingObservation in researchOutcomePerinatologyPositioning AttributePremature BirthPreventionReproducibilityResearchResearch EthicsScienceSourceSurveysSystemThinkingTrainingTraining ProgramsTranslational ResearchUniversitiesbasebiomedical informaticscareercareer developmentdesigninnovationmedical specialtiesonline coursepopulation healthprogramsskillstranslational medicinetranslational pipeline
项目摘要
The core objective of this heavily revised and re-invigorated Stanford CTSA-associated KL2 program is
to provide high-quality personalized training in clinical and translational research and education (CTRE) to junior
faculty. Training will encompass the entire translational spectrum from T0-1 to T4, irrespective of the individual
Scholar’s current research focus. At the completion of their training, these young “CTR” Scholars will have
acquired the knowledge, skills, and attitudes necessary to address impactful questions, author grants and
manuscripts, compete effectively for external funding, develop mentoring and team building strategies, and
understand how to develop and follow their career development plans. We aim to enable our Scholars to excel
at their research-based positions in academia and also in government, not-for-profit, and industry-based
biomedical research enterprises. We expect that the research careers of our Scholars will be focused on
innovation, discovery, implementation, and dissemination of new knowledge, a longstanding Stanford tradition.
Specific components will include:
• Didactic instruction embedded within a degree opportunity or a more customized selection of courses
• A multi-faceted mentoring program, starting with a Career Development Plan, that will meld the
perspectives of research mentors with the career mentors and KL2 leadership
• A professional development core, organized to cover all topics and competencies identified by
NCATS and the CTSAs as central to CTR including research ethics, research reproducibility,
compliance, and good clinical practice
• Training in team science, community-engaged participatory research, and regulatory sciences within
a comprehensive life-course framework.
Stanford KL2 appointments will be for two years. We are applying for 4 or 5 new positions per year to
result in nine enrolled KL2 Scholars in our training program at steady state. All future Scholars will be on a
confirmed path to become Stanford junior faculty. Rigorous short-, medium-, and long-term metrics for
evaluations of trainees and the program itself, are designed to assure continuous improvement. Our newly
reframed KL2 program will emphasize teamwork and elements of design-based thinking, under the premise that
clinical and translational medicine at all stages is a coherent scientific specialty that bridges all disciplinary areas,
spanning the life course, from the discovery of targets for treatment and prevention to effecting change at the
bedside and advancing the health of populations.
这项经过重大修订和重新启发的Stanford CTSA相关KL2计划的核心目标是
为临床和翻译研究和教育(CTRE)提供高质量的个性化培训
学院。培训将涵盖从T0-1到T4的整个翻译光谱,无论个人如何
学者目前的研究重点。培训完成后,这些年轻的“ CTR”学者将拥有
获得了知识,技能和参加,以解决有影响力的问题,作者赠款和
手稿,有效竞争外部资金,发展心理和团队建设策略,以及
了解如何制定和遵循他们的职业发展计划。我们的目的是使我们的学者表现出色
在他们在学术界以及政府,非营利性和行业的基于研究的职位上
生物医学研究企业。我们预计我们的学者的研究职业将集中在
新知识的创新,发现,实施和传播,这是斯坦福大学的长期传统。
特定组件将包括:
•教学教学嵌入了学位机会或更定制的课程选择
•从职业发展计划开始的多方面心理计划,该计划将融合
与职业导师和KL2领导力的研究导师的观点
•专业发展核心,旨在涵盖所有主题和能力
NCAT和CTSA作为CTR的中心,包括研究伦理,研究可重复性,
合规性和良好的临床实践
•在团队科学,社区参与的参与研究和监管科学方面的培训
一个全面的生活课程框架。
斯坦福KL2任命将为两年。我们每年申请4或5个新职位
在我们的稳定状态下,在我们的培训计划中,有9名参加了KL2学者。所有未来的学者都将在
确认成为斯坦福大学初级教师的道路。严格的短期,中,长期指标
对学员和计划本身的评估旨在确保持续改进。我们的新
重塑KL2计划将在以下前提下强调团队合作和基于设计思维的要素
在各个阶段,临床和翻译的医学是一个连贯的科学专业,它桥接了所有纪律领域,
跨越生命过程,从发现治疗和预防目标到有效的变化
床边并提高人口健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven N. Goodman其他文献
Impact of gene expression profiling tests on breast cancer outcomes.
基因表达谱测试对乳腺癌结果的影响。
- DOI:
10.23970/ahrqepcerta160 - 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
L. Marchionni;Renee F Wilson;S. Marinopoulos;A. Wolff;G. Parmigiani;E. Bass;Steven N. Goodman - 通讯作者:
Steven N. Goodman
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
羟氯喹和氯喹治疗 COVID-19 的死亡率结果:随机试验的国际协作荟萃分析
- DOI:
10.1101/2020.09.16.20194571 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
C. Axfors;Andreas M. Schmitt;P. Janiaud;J. van ’t Hooft;S. Abd;Ehab F. Abdo;Benjamin S. Abella;Javed Akram;Ravi K. Amaravadi;Derek C Angus;Y. Arabi;Shehnoor Azhar;Lindsey R. Baden;Arthur W. Baker;L. Belkhir;Thomas Benfield;M. A. Berrevoets;Cheng;Tsung;Shu;Chien;Wei;Yehuda Z. Cohen;Lisa N. Cowan;O. Dalgard;F. F. de Almeida e Val;M. V. D. de Lacerda;G. D. de Melo;L. Derde;Vincent Dubée;A. Elfakir;Anthony C Gordon;C. Hernández;Thomas E Hills;Andy I. M. Hoepelman;Yi;B. Igau;Ronghua Jin;Felipe Jurado;K. S. Khan;Peter G. Kremsner;Benno Kreuels;Cheng;Thuy Le;Yi;Wu;Tse;M. Lyngbakken;Colin McArthur;B. McVerry;Patricia A Meza;W. Monteiro;Susan C. Morpeth;Ahmad Mourad;Mark J. Mulligan;S. Murthy;Susanna Naggie;S. Narayanasamy;A. Nichol;L. Novack;Sean M. O’Brien;N. Okeke;L. Perez;Rogelio Pérez;Laurent Perrin;A. Remigio;N. Rivera;Frank W. Rockhold;S. Rodríguez;Robert Rolfe;Rossana Rosa;H. Røsjø;V. Sampaio;Todd B Seto;Muhammad Shehzad;Shaimaa Soliman;Jason E. Stout;I. Thirión;Andrea B Troxel;Ting;Nicholas A. Turner;Robert J. Ulrich;S. Walsh;Steven A. Webb;Jesper M. Weehuizen;M. Velinova;Hon;R. Wrenn;F. Zampieri;Wu Zhong;D. Moher;Steven N. Goodman;John P. A. Ioannidis;L. Hemkens - 通讯作者:
L. Hemkens
Statins and cancer: a case of meta-uncertainty.
他汀类药物和癌症:元不确定性的一个例子。
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:5.9
- 作者:
E. Guallar;Steven N. Goodman - 通讯作者:
Steven N. Goodman
Basic Science Reviews
基础科学评论
- DOI:
10.7326/0003-4819-117-5-439 - 发表时间:
1992 - 期刊:
- 影响因子:39.2
- 作者:
Robert H. Fletcher;Suzanne W. Fletcher;J. R. Elkinton;Edward J. Huth;P. F. Dans;E. Abrutyn;J. L. Abruzzo;E. Adlin;M. Black;Leonard E. Braitman;Paul Epstein;Steven N. Goodman;D. G. Haller;W. Laskey;Michael A. Lacombe;Kathleen Case;P. Fried;K. H. Antman - 通讯作者:
K. H. Antman
MP33-12 THE NATURAL HISTORY OF VOIDING EFFICIENCY FOLLOWING CORRECTION OF PARTIAL BLADDER OUTLET OBSTRUCTION IN WOMEN WITH PROLAPSE (2009-2015)
- DOI:
10.1016/j.juro.2018.02.1083 - 发表时间:
2018-04-01 - 期刊:
- 影响因子:
- 作者:
Amy D. Dobberfuhl;Robyn K. Shaffer;Steven N. Goodman;Bertha Chen - 通讯作者:
Bertha Chen
Steven N. Goodman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven N. Goodman', 18)}}的其他基金
Project ImpACT:Important Achievements of Clinical Trial
项目影响:临床试验重要成果
- 批准号:
6758543 - 财政年份:2003
- 资助金额:
$ 110.22万 - 项目类别:
Project ImpACT:Important Achievements of Clinical Trial
项目影响:临床试验重要成果
- 批准号:
6932111 - 财政年份:2003
- 资助金额:
$ 110.22万 - 项目类别:
Project ImpACT:Important Achievements of Clinical Trial
项目影响:临床试验重要成果
- 批准号:
6599525 - 财政年份:2003
- 资助金额:
$ 110.22万 - 项目类别:
相似国自然基金
湖州师范学院理论物理强子共振态和核物理方向学术交流与平台建设
- 批准号:
- 批准年份:2021
- 资助金额:50 万元
- 项目类别:
“抗疫精神”对医护职业偏好、行为偏好的短期与长期影响:基于医务人员和医学院学生的研究
- 批准号:72173093
- 批准年份:2021
- 资助金额:48 万元
- 项目类别:面上项目
湖州师范学院理论物理奇特核结构与反应方向学术交流与平台建设
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:专项基金项目
数学院士专家大学中学系列科普活动
- 批准号:12026425
- 批准年份:2020
- 资助金额:20.0 万元
- 项目类别:数学天元基金项目
量子体系中的能量传输与能量转换学院
- 批准号:11981240427
- 批准年份:2019
- 资助金额:1.5 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
明尼苏达大学临床与转化科学研究所 (UMN CTSI)
- 批准号:
10763967 - 财政年份:2023
- 资助金额:
$ 110.22万 - 项目类别:
FORUM ON MEDICAL AND PUBLIC HEALTH PREPAREDNESS FOR DISASTERS AND EMERGENCIES AND ACTION COLLABORATIVE ON DISASTERS/PUBLIC HEALTH EMERGENCY RESEARCH
灾害和紧急情况医疗和公共卫生防备论坛以及灾害/公共卫生紧急情况研究行动合作
- 批准号:
10937101 - 财政年份:2023
- 资助金额:
$ 110.22万 - 项目类别:
2023 Cellular and Molecular Mechanisms of Toxicity Gordon Research Conference and Seminar
2023细胞和分子毒性机制戈登研究会议暨研讨会
- 批准号:
10672627 - 财政年份:2023
- 资助金额:
$ 110.22万 - 项目类别:
The Cancer Research Scholars Program (CRSP): Exploring Research Across the Cancer Continuum and into Underserved Communities
癌症研究学者计划 (CRSP):探索癌症连续体和服务不足社区的研究
- 批准号:
10663972 - 财政年份:2021
- 资助金额:
$ 110.22万 - 项目类别: